临床试验/NCT01299077

NCT01299077已完成不适用

A Retrospective Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar Disc Degenerative Disease in China

Eisai China Inc.10 个研究点分布在 1 个国家目标入组 478 人开始时间: 2010年6月最近更新: 2011年12月28日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Eisai China Inc.
入组人数: 478
试验地点: 10
主要终点: Overall Satisfaction Degree After 2 Weeks Treatment of Triple Therapy (MBL+MYO+NSAID).

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The purpose of this study is to observe the overall satisfaction of patients with degenerative disc disease after receiving triple therapy.

详细描述

DDD (lumbar disc degenerative disease ) patients who have been prescribed triple therapy (MBL+ MYO+ NSAIDs) over 2 weeks of triple therapy were enrolled in the study. They were asked to assess their overall satisfaction degree on triple therapy.

研究设计

研究类型: Observational
观察模型: Case Only
时间视角: Retrospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

未提供

排除标准

未提供

结局指标

主要结局

Overall Satisfaction Degree After 2 Weeks Treatment of Triple Therapy (MBL+MYO+NSAID).

时间窗: 2 weeks

The measurement of overall satisfaction degree was in three scales, that was satisfactory, just so so and dissatisfactory. The measurement was estimated by both the physicians and the patients respectively.

次要结局

Safety Data During Triple Therapy.(2 weeks)
Onset Time of Symptom Relief.(2 weeks)
Japanese Orthopedic Association (JOA) Score(Baseline and 2 weeks)
Visual Analogue Scale (VAS) Score(Baseline and 2 weeks)

研究者

发起方

Eisai China Inc.

申办方类型

Industry

责任方

Sponsor

研究点 (10)

Loading locations...

相似试验

已完成

不适用

Benepali® PEN Patient Satisfaction SurveySpondyloarthropathiesRheumatoid Arthritis

NCT03327454Biogen500

已完成

不适用

Disc Resorption in Lumbar and Cervical Disc Herniation Patients Receiving Integrative Korean Medicine TreatmentLumbar Intervertebral Disc DisplacementCervical Intervertebral Disc Displacement

NCT02841163Jaseng Medical Foundation505

已完成

不适用

Comparison of DISCOVER™ Artificial Cervical Disc and ACDF for Treatment of Cervical DDD (IDE Study)Cervical Degenerative Disc Disease

NCT00432159DePuy Spine500

已完成

不适用

Dapagliflozin Patient Satisfaction SurveyDiabetes Mellitus, Type 2

NCT02805283AstraZeneca653

招募中

不适用

Observational Study of Patients Who Underwent Diagnostic Investigation (Prostate Biopsy) and/or Radical Prostatectomy Surgery.Prostate Cancer

NCT06397755IRCCS San Raffaele20,000